SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $11,164,000 | +28.8% | 745,240 | +4.6% | 0.01% | +20.0% |
| Q1 2016 | $8,670,000 | -21.7% | 712,388 | +2.4% | 0.01% | -28.6% |
| Q4 2015 | $11,068,000 | +5.2% | 695,669 | +1.4% | 0.01% | 0.0% |
| Q3 2015 | $10,520,000 | -30.2% | 686,216 | +10.7% | 0.01% | -22.2% |
| Q2 2015 | $15,068,000 | +7.1% | 619,816 | +2.4% | 0.01% | 0.0% |
| Q1 2015 | $14,074,000 | +29.8% | 605,346 | +40.1% | 0.01% | +28.6% |
| Q4 2014 | $10,846,000 | -0.3% | 431,928 | +23.5% | 0.01% | -12.5% |
| Q3 2014 | $10,877,000 | +49.8% | 349,755 | +24.5% | 0.01% | +60.0% |
| Q2 2014 | $7,263,000 | +111.6% | 280,855 | +91.2% | 0.01% | +66.7% |
| Q1 2014 | $3,432,000 | +20.5% | 146,858 | +30.9% | 0.00% | +50.0% |
| Q4 2013 | $2,847,000 | +114.4% | 112,182 | +72.3% | 0.00% | +100.0% |
| Q3 2013 | $1,328,000 | – | 65,111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |